A new study found that low or absent disease activity, hydroxychloroquine (HCQ) use, and gradual reduction of GC dosing can ...

A new study published in JAMA Dermatology reveals that people with cutaneous lupus are 72 per cent more likely to develop ...

Cutaneous lupus erythematosus is associated with an increased risk for ASCVD, similar to the risk seen in association with SLE.

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

Results showed that systemic lupus carries the greatest risk for heart health, more than doubling a person’s risk of heart ...

Children with lupus nephritis who receive belimumab achieve treatment targets faster, and can taper glucocorticoids earlier, than those using standard immunotherapy, according to data published in ...

Patients with cutaneous lupus erythematosus may be at an increased risk for atherosclerotic cardiovascular disease, even more ...

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

New research reveals how social determinants of health significantly affect lupus treatment outcomes in Black patients, with ...

Objective Evaluating the potential role of neuromuscular ultrasonography (NMUS) in assessing optic nerve affection in ...

It takes courage to be our genuine selves, writes columnist Candace Semien, who shares a couple powerful prayers for lupus.

The National Institutes of Health has awarded an Oklahoma Medical Research Foundation scientist a $4.1 million grant to study ...